ENG and cancer: Since the early 1990 s, accumulated information supports the involvement of both membrane-bound endoglin and soluble endoglin in a wide spectrum of pathophysiological processes, including angiogenesis, endothelial dysfunction, fibrosis, inflammation, vascular pathology, hemostasis, hypertension, and cancer.